Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/kyowa-hakko-bio-co-ltd-on-health-canada-inspection-list-9449.pdf
https://www.prnewswire.com/news-releases/kyowa-hakko-acclaimed-by-frost--sullivan-for-its-non-gmo-allergen-free-immune-support-paraprobiotic-ingredient-immuse-301379881.html
https://www.prnewswire.com/news-releases/mei-pharma-and-kyowa-kirin-announce-first-patient-with-marginal-zone-lymphoma-dosed-in-expanded-global-phase-2-tidal-study-evaluating-zandelisib-301306621.html
https://www.fiercepharma.com/manufacturing/japan-s-kyowa-kirin-reorganizes-quality-responsibilities
https://www.pharmacompass.com/pdf/news/kyowa-hakko-bio-on-health-canada-inspection-list-1542450249.pdf
https://www.reuters.com/article/us-abbvie-biosimilars/eu-approves-fifth-copy-of-abbvies-18-billion-drug-humira-idUSKCN1M011N
https://www.cnbc.com/2018/09/20/reuters-america-mylan-fujifilm-win-eu-okay-for-copy-of-abbvies-humira.html
https://www.biopharmadive.com/news/kyowa-hakko-picks-up-warning-letter-from-the-fda/531224/
https://www.pharmacompass.com/pdf/news/kyowa-hakko-bio-receives-fda-warning-letter-1534914076.pdf
https://www.raps.org/news-and-articles/news-articles/2018/8/fda-warns-drugmakers-in-asia-over-poor-data-integr?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2021%20August